Developer docs
API playgroundTry for free, no card

Search company profiles

West Cancer Center

Full company profile

uuid000cd1z

Namestring
West Cancer Center
Legal namestring
West Cancer Center & Research Institute
Company typeenum
Private
Founded yearint
1978
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersBrighton, United States
HQ citystring
Brighton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices11 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology care services, cancer treatment center, radiation oncology therapy, clinical trials research, multidisciplinary cancer care
Industry5 codes
1Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryYes
2Medical Oncology
CodeHLAKAFABPrimaryNo
3Radiation Oncology
CodeHLAKAFACPrimaryNo
4Surgical Oncology
CodeHLAKAFAGPrimaryNo
5Gynecologic Oncology & Women’s Cancer Centers
CodeHLAFAJAKPrimaryNo
NAICS code3 codes
  • Ambulatory Health Care Services621
  • Offices of Physicians62111
  • Diagnostic Imaging Centers621512
SIC code2 codes
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Oncology Care Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Oncology Care Services
TypeSubscription Recurring
Description

West Cancer Center generates revenue through direct patient care services including medical oncology (chemotherapy, immunotherapy), radiation oncology, surgical oncology, diagnostic imaging, pathology, pharmacy, and supportive care services. Revenue is derived from insurance reimbursements and patient payments for comprehensive cancer treatment services.

westcancercenter.org
Marketing channels12 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 3 records shown
1Margaret West Comprehensive Breast Center
Description

A comprehensive breast health center offering mammograms, biopsies, MRIs, ultrasounds, and breast surgical oncology services located within the Wolf River/Germantown campus.

westcancercenter.org
+2 more records
Core offering1 text field

West Cancer Center & Research Institute is a multi-location oncology network providing comprehensive adult cancer care across 11 clinical campuses in the Mid-South region. Core services include medical oncology (chemotherapy, immunotherapy), radiation oncology, surgical oncology, diagnostic imaging, pathology, pharmacy, genetic counseling, palliative care, and supportive services. The center delivers specialized treatment technologies such as GammaTile Therapy, ProSense cryoablation, MRI-guided brachytherapy, and PSMA PET/CT imaging, alongside a clinical trials program through the OneR/OneOncology research network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Over 68,000 patients treated annually
+4 more records
Product overview1 text field

West Cancer Center & Research Institute operates as a multi-location oncology network providing comprehensive adult cancer care through a platform-plus-specialized-services model. The core CareSpace digital patient portal (accessible via web and mobile app) serves as the central gateway for patient engagement, integrated with the Willowglade Unified Digital Patient Experience Platform. Clinical care is delivered across 11 campuses in Tennessee, Mississippi, Arkansas, and beyond, supported by treatment technologies including ProSense® cryoablation (FDA-cleared for early-stage breast cancer), GammaTile radiation therapy (for brain tumors), MRI-guided brachytherapy (for cervical cancer), PSMA PET/CT imaging (for prostate cancer), and AI-assisted intraoperative imaging (for lumpectomy). The Proto Hologram platform enables immersive virtual visits for rural patients. Research capabilities are expanded through the OneR/OneOncology clinical trial network and regular tumor board conferences. The Margaret West Comprehensive Breast Center provides specialized breast health services, while the Lifesigns Executive Wellness Program offers preventive health assessments.

Product and service1 record
1Medical Oncology (Chemotherapy and Immunotherapy)
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-07
Description

Two exclusive strategic partnership agreements combining IDEOlogy Health's multi-channel medical education platforms with West's clinical expertise spanning 46+ years, 113 providers, and 68,000 patients annually. Aims to elevate physician and Advanced Practice Provider education in oncology care and accelerate integration of emerging research into clinical practice across the Mid-South region.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-03-12
Description

Strategic relationship to deploy the Willowglade Unified Digital Patient Experience Platform aimed at improving patient communication access and streamlining care interactions. Long-term collaboration focused on continuous improvement guided by patient feedback and measurable outcomes, reducing technical integration complexity while enhancing personalized communication throughout the care journey.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-21
Description

Atlas Oncology Partners officially launched in Memphis, Tennessee in partnership with West Cancer Center to support cancer care through an embedded, value-based care model. Plans to expand across the Southeastern US by 2026 to enhance care delivery and reduce treatment costs.

Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2022-07-13
Description

Collaboration with Semmes Murphey neurosurgeons (Dr. Andrew Boucher, Dr. Madison Michael II) and West radiation oncologist Dr. Matthew Ballo to offer GammaTile Therapy - first in Mid-South. Neurosurgeons perform implantation during brain tumor removal surgery.

Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2022-07-13
Description

First two GammaTile Therapy patients treated at St. Francis Hospital in Memphis. Hospital provides surgical facility for the novel brain tumor radiation treatment delivered in collaboration with Semmes Murphey and West Cancer Center.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Partnership in study with OneOncology and Genentech examining elements of inequity in next generation sequencing (NGS) for patients with advanced non-small cell lung cancer.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-06-01
Description

Multi-million dollar investment partnership to advance and increase access to cancer care in the Mid-South. Includes first-in-the-Mid-South cancer urgent care center and collaboration on comprehensive cancer services.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-03-01
Description

Partnership to bring cancer care to Midtown Memphis location. Effective March 1, 2021, the West Cancer Center Midtown location transitioned to a hospital outpatient department of Regional One Health. Joint relationship providing comprehensive cancer services at Midtown location.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-11-01
Description

West Cancer Center is an affiliate of OneOncology, joining OneR research network to expand clinical trial offerings and oncology research knowledge. Partnership facilitates collaborations on clinical trials, scientific research, and real-world data studies to advance personalized cancer care at community oncology centers.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-11-01
Description

Partnership through OneR network for clinical trials targeting actionable mutations in cancer. Collaboration facilitates clinical trials, scientific research, and real-world data studies with Genentech to advance personalized cancer care.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Largest independent oncology physician practice in Tennessee, also a OneOncology affiliate with multi-campus community oncology operations across the state. Most directly comparable to West on geography, multi-specialty oncology model, and OneOncology network affiliation.

TypeDirect peer
Description

Large independent community oncology practice operating across Florida with extensive clinical trial participation and value-based care contracting. Comparable to West on multi-site community oncology model, research integration, and scale of patient volume.

TypeDirect peer
Description

Multi-state community oncology practice with value-based care model focus and medical oncology, radiation oncology, and clinical trial services. Comparable on the value-based community oncology thesis West is pursuing via Atlas Oncology Partners.

TypeBroad incumbent
Description

National network of independent community oncology practices of which West is an affiliate. Comparable as the broader platform West participates in for clinical research, drug purchasing, and operational support; competes for talent and contracts at the network level.

TypeBroad incumbent
Description

HCA Healthcare's oncology research and treatment network operating across the U.S. with extensive clinical trial programs and community oncology partnerships. Comparable to West on multi-site oncology research and treatment delivery model at significantly larger scale.

TypeBroad incumbent
Description

Large national network of community oncology practices affiliated with McKesson, providing drug distribution, technology, and research infrastructure. Comparable to West on multi-site community oncology model with broader geographic reach.

TypeRegional player
Description

NCI-designated academic comprehensive cancer center in Nashville, Tennessee, competing for Mid-South oncology patients, specialist talent, and clinical trial enrollment. Comparable to West on Tennessee-based cancer care delivery at academic-center scale.

TypeRegional player
Description

NCI-designated cancer center in Atlanta serving the Southeastern U.S. with research, multi-specialty treatment, and clinical trial programs. Comparable to West on Southeast U.S. oncology footprint and academic-community oncology research integration.

TypeBroad incumbent
Description

NCI-designated comprehensive cancer center in Tampa, Florida, operating community affiliate network across the Southeast. Comparable to West on Southeast oncology footprint and the academic-affiliate model of multi-site cancer care delivery.

TypeOthers
Description

Memphis-area health system that operates West Cancer Center's Midtown campus as a hospital outpatient department partnership. Comparable as a structural partner rather than competitor, illustrating the hospital-system integration pattern across West's footprint.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles18 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

West Cancer Center

Oncology Care Serviceswestcancercenter.org

West Cancer Center firmographics

Firmographics
Name
West Cancer Center
Legal name
West Cancer Center & Research Institute
Website
http://www.westcancercenter.org
Company type
Private
Founded year
1978
Operating status
Operating
Headcount range
251–500 employees
Ownership category
akta.pro rank

West Cancer Center industry classification

Industry
Product category
Oncology Care Services
NAICS
Ambulatory Health Care Services (621), Offices of Physicians (62111), Diagnostic Imaging Centers (621512)
SIC
Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
akta.pro secondary industries
Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC), Surgical Oncology (HLAKAFAG), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK)

Keywords

  • Oncology care services
  • Cancer treatment center
  • Radiation oncology therapy
  • Clinical trials research
  • Multidisciplinary cancer care

Where West Cancer Center is headquartered

Location

Headquarters

HQ city
Brighton
HQ country
United States
HQ region
North America

Offices11 records

Markets served

West Cancer Center business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Oncology Care Services: West Cancer Center generates revenue through direct patient care services including medical oncology (chemotherapy, immunotherapy), radiation oncology, surgical oncology, diagnostic imaging, pathology, pharmacy, and supportive care services. Revenue is derived from insurance reimbursements and patient payments for comprehensive cancer treatment services.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels12 records

West Cancer Center product offering

Product offering

Core offering

West Cancer Center & Research Institute is a multi-location oncology network providing comprehensive adult cancer care across 11 clinical campuses in the Mid-South region. Core services include medical oncology (chemotherapy, immunotherapy), radiation oncology, surgical oncology, diagnostic imaging, pathology, pharmacy, genetic counseling, palliative care, and supportive services. The center delivers specialized treatment technologies such as GammaTile Therapy, ProSense cryoablation, MRI-guided brachytherapy, and PSMA PET/CT imaging, alongside a clinical trials program through the OneR/OneOncology research network.

Product overview

West Cancer Center & Research Institute operates as a multi-location oncology network providing comprehensive adult cancer care through a platform-plus-specialized-services model. The core CareSpace digital patient portal (accessible via web and mobile app) serves as the central gateway for patient engagement, integrated with the Willowglade Unified Digital Patient Experience Platform. Clinical care is delivered across 11 campuses in Tennessee, Mississippi, Arkansas, and beyond, supported by treatment technologies including ProSense® cryoablation (FDA-cleared for early-stage breast cancer), GammaTile radiation therapy (for brain tumors), MRI-guided brachytherapy (for cervical cancer), PSMA PET/CT imaging (for prostate cancer), and AI-assisted intraoperative imaging (for lumpectomy). The Proto Hologram platform enables immersive virtual visits for rural patients. Research capabilities are expanded through the OneR/OneOncology clinical trial network and regular tumor board conferences. The Margaret West Comprehensive Breast Center provides specialized breast health services, while the Lifesigns Executive Wellness Program offers preventive health assessments.

Differentiator

Problem solved

Functional benefit

Brands

  • Margaret West Comprehensive Breast Center: A comprehensive breast health center offering mammograms, biopsies, MRIs, ultrasounds, and breast surgical oncology services located within the Wolf River/Germantown campus.
  • CareSpace Patient Portal
  • Lifesigns

Products and services

  • Medical Oncology (Chemotherapy and Immunotherapy)

Quantifiable outcome

  • Over 68,000 patients treated annually
  • +4 more outcomes

Companies that use West Cancer Center

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

West Cancer Center technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability2 records

Feature6 records

West Cancer Center partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • IDEOlogy HealthcoreStrategic or Co-development Partner · 7 April 2026Two exclusive strategic partnership agreements combining IDEOlogy Health's multi-channel medical education platforms with West's clinical expertise spanning 46+ years, 113 providers, and 68,000 patients annually. Aims to elevate physician and Advanced Practice Provider education in oncology care and accelerate integration of emerging research into clinical practice across the Mid-South region.
  • Willowglade TechnologiescoreTechnology or Integration · 12 March 2026Strategic relationship to deploy the Willowglade Unified Digital Patient Experience Platform aimed at improving patient communication access and streamlining care interactions. Long-term collaboration focused on continuous improvement guided by patient feedback and measurable outcomes, reducing technical integration complexity while enhancing personalized communication throughout the care journey.
  • Atlas Oncology PartnerscoreStrategic or Co-development Partner · 21 January 2026Atlas Oncology Partners officially launched in Memphis, Tennessee in partnership with West Cancer Center to support cancer care through an embedded, value-based care model. Plans to expand across the Southeastern US by 2026 to enhance care delivery and reduce treatment costs.
  • Semmes MurpheycoreImplementation/ SI/ Consulting Partner · 13 July 2022Collaboration with Semmes Murphey neurosurgeons (Dr. Andrew Boucher, Dr. Madison Michael II) and West radiation oncologist Dr. Matthew Ballo to offer GammaTile Therapy - first in Mid-South. Neurosurgeons perform implantation during brain tumor removal surgery.
  • St. Francis HospitalcoreImplementation/ SI/ Consulting Partner · 13 July 2022First two GammaTile Therapy patients treated at St. Francis Hospital in Memphis. Hospital provides surgical facility for the novel brain tumor radiation treatment delivered in collaboration with Semmes Murphey and West Cancer Center.
  • Flatiron HealthminorStrategic or Co-development Partner · 1 January 2022Partnership in study with OneOncology and Genentech examining elements of inequity in next generation sequencing (NGS) for patients with advanced non-small cell lung cancer.
  • Saint Francis HealthcarecoreStrategic or Co-development Partner · 1 June 2021Multi-million dollar investment partnership to advance and increase access to cancer care in the Mid-South. Includes first-in-the-Mid-South cancer urgent care center and collaboration on comprehensive cancer services.
  • Regional One HealthcoreStrategic or Co-development Partner · 1 March 2021Partnership to bring cancer care to Midtown Memphis location. Effective March 1, 2021, the West Cancer Center Midtown location transitioned to a hospital outpatient department of Regional One Health. Joint relationship providing comprehensive cancer services at Midtown location.
  • OneOncology / OneRcoreStrategic or Co-development Partner · 1 November 2020West Cancer Center is an affiliate of OneOncology, joining OneR research network to expand clinical trial offerings and oncology research knowledge. Partnership facilitates collaborations on clinical trials, scientific research, and real-world data studies to advance personalized cancer care at community oncology centers.
  • GenentechcoreStrategic or Co-development Partner · 1 November 2020Partnership through OneR network for clinical trials targeting actionable mutations in cancer. Collaboration facilitates clinical trials, scientific research, and real-world data studies with Genentech to advance personalized cancer care.

Scale indicators10 records

Recent moves9 records

Expansion highlights6 records

West Cancer Center competitors and assessment

Company assessment

Direct peers

  • Tennessee Oncology: Largest independent oncology physician practice in Tennessee, also a OneOncology affiliate with multi-campus community oncology operations across the state. Most directly comparable to West on geography, multi-specialty oncology model, and OneOncology network affiliation.
  • Florida Cancer Specialists & Research Institute: Large independent community oncology practice operating across Florida with extensive clinical trial participation and value-based care contracting. Comparable to West on multi-site community oncology model, research integration, and scale of patient volume.
  • The Oncology Institute: Multi-state community oncology practice with value-based care model focus and medical oncology, radiation oncology, and clinical trial services. Comparable on the value-based community oncology thesis West is pursuing via Atlas Oncology Partners.

Broad incumbents

  • OneOncology: National network of independent community oncology practices of which West is an affiliate. Comparable as the broader platform West participates in for clinical research, drug purchasing, and operational support; competes for talent and contracts at the network level.
  • Sarah Cannon Research Institute: HCA Healthcare's oncology research and treatment network operating across the U.S. with extensive clinical trial programs and community oncology partnerships. Comparable to West on multi-site oncology research and treatment delivery model at significantly larger scale.
  • US Oncology Network (McKesson): Large national network of community oncology practices affiliated with McKesson, providing drug distribution, technology, and research infrastructure. Comparable to West on multi-site community oncology model with broader geographic reach.
  • Moffitt Cancer Center: NCI-designated comprehensive cancer center in Tampa, Florida, operating community affiliate network across the Southeast. Comparable to West on Southeast oncology footprint and the academic-affiliate model of multi-site cancer care delivery.

Regional players

  • Vanderbilt-Ingram Cancer Center: NCI-designated academic comprehensive cancer center in Nashville, Tennessee, competing for Mid-South oncology patients, specialist talent, and clinical trial enrollment. Comparable to West on Tennessee-based cancer care delivery at academic-center scale.
  • Winship Cancer Institute of Emory University: NCI-designated cancer center in Atlanta serving the Southeastern U.S. with research, multi-specialty treatment, and clinical trial programs. Comparable to West on Southeast U.S. oncology footprint and academic-community oncology research integration.

Others

  • Regional One Health: Memphis-area health system that operates West Cancer Center's Midtown campus as a hospital outpatient department partnership. Comparable as a structural partner rather than competitor, illustrating the hospital-system integration pattern across West's footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

West Cancer Center social profiles

Digital presence

West Cancer Center financial estimates

Financial estimate

Revenue estimate

Valuation estimate

West Cancer Center leadership team

Management profile

Number of profiles

Profiles18 records

West Cancer Center subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

West Cancer Center funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

West Cancer Center M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about West Cancer Center

What does West Cancer Center do?

West Cancer Center & Research Institute is a multi-location oncology network providing comprehensive adult cancer care across 11 clinical campuses in the Mid-South region. Core services include medical oncology (chemotherapy, immunotherapy), radiation oncology, surgical oncology, diagnostic imaging, pathology, pharmacy, genetic counseling, palliative care, and supportive services. The center delivers specialized treatment technologies such as GammaTile Therapy, ProSense cryoablation, MRI-guided brachytherapy, and PSMA PET/CT imaging, alongside a clinical trials program through the OneR/OneOncology research network.

Is West Cancer Center a public or private company?

West Cancer Center is a private company. It is classified as management employee owned and is currently operating.

When was West Cancer Center founded?

West Cancer Center was founded in 1978. It employs 251 to 500 people.

Where is West Cancer Center based?

West Cancer Center is headquartered in Brighton, United States, in the North America region.

How does West Cancer Center make money?

One revenue line is on record: oncology Care Services.

Who are West Cancer Center's main competitors?

Direct peers on record are Tennessee Oncology, Florida Cancer Specialists & Research Institute and The Oncology Institute. Broad incumbents are OneOncology, Sarah Cannon Research Institute, US Oncology Network (McKesson) and Moffitt Cancer Center. Regional players are Vanderbilt-Ingram Cancer Center and Winship Cancer Institute of Emory University. Regional One Health is listed as an others.

Does West Cancer Center have an API?

No public API is recorded for West Cancer Center.

What industry is West Cancer Center in?

West Cancer Center's product category is Oncology Care Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 621 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AijournWest Cancer Center Receives IRB Approval to Commence IceCure’s ChoICE Study for Breast Cancer CryoablationIceCure Medical received Institutional Review Board approval from West Cancer Center & Research Institute to commence its ChoICE post-marketing study for the ProSense cryoablation system in treating low-risk breast cancer. The study, which is expected to begin patient enrollment in the coming weeks, will evaluate the device's efficacy alongside endocrine therapy in women aged 70 and older across 30 participating sites. This approval advances the clinical evidence base for IceCure's minimally invasive tumor destruction technology following its prior FDA marketing authorization.Stock TitanIceCure Gets IRB Approval for ChoICE Breast Cancer StudyIceCure Medical received Institutional Review Board approval from West Cancer Center & Research Institute to commence its ChoICE post-marketing study for ProSense® cryoablation in the treatment of low-risk breast cancer. Patient enrollment is expected to begin in the coming weeks across 30 participating sites, aiming to generate real-world data for patients aged 70 and older. This development builds on previous FDA marketing authorization secured by IceCure following successful ICE3 clinical trial results.PR NewswireWest Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer CryoablationThe Institutional Review Board of West Cancer Center & Research Institute in Germantown, Tennessee, has approved IceCure Medical Ltd.'s post-marketing study for the ProSense® cryoablation system in treating low-risk breast cancer. This study, known as the ChoICE Study, aims to enroll a total of 400 patients across 30 sites, enhancing access to minimally invasive treatment for eligible patients. The approval reflects IceCure's ongoing commitment to advancing cancer care with its innovative cryoablation technology.Stock TitanIceCure Names First U.S. Site for Up to 400-Patient StudyIceCure Medical Ltd. announced that the West Cancer Center & Research Institute in Germantown, Tennessee will serve as the first U.S. clinical site for its post-marketing ChoICE study evaluating ProSense® cryoablation for low-risk breast cancer treatment. The study, following FDA marketing authorization in October 2025, will enroll up to 400 patients across 30 U.S. sites to generate real-world evidence supporting broader clinical adoption. The participating sites will operate as both ChoICE Study centers and active commercial sites, enabling treatment of eligible patients both within and outside the study.PR NewswireWest Cancer Center and IDEOlogy Health Announce Strategic Partnership to Advance Patient-Centered Oncology Education and CareWest Cancer Center & Research Institute and IDEOlogy Health announced two exclusive strategic partnership agreements to elevate physician and Advanced Practice Provider education in oncology care. The collaboration combines IDEOlogy Health's multi-channel medical education platforms with West's clinical expertise, which spans more than 46 years, 113 specialized providers, and care for over 68,000 patients annually. The partnership aims to accelerate the integration of emerging research into clinical practice and improve patient outcomes across the Mid-South region.EIN PresswireWillowglade Technologies and West Cancer Center & Research Institute Focus on Advancing the Digital Patient ExperienceWillowglade Technologies announced a strategic relationship with West Cancer Center & Research Institute to deploy the Willowglade Unified Digital Patient Experience Platform, aimed at improving patient communication access and streamlining care interactions. The partnership focuses on reducing technical integration complexity while enhancing patients' access to consistent, personalized communication throughout their care journey. Both organizations described the collaboration as a long-term relationship focused on continuous improvement guided by patient feedback and measurable outcomes.GlobeNewswireProto Hologram Inventor named to TIME100 Health ListDavid Nussbaum, founder of Proto Inc., was named to TIME's 2025 Health list for his hologram and AI healthcare technology. Proto's system beams doctors to clinics, with West Cancer Center launching the first real doctor-patient hologram appointments in 2024. The company is also used in education and other sectors.YahooProto Hologram Inventor named to TIME100 Health ListTIME has named David Nussbaum, Founder and Chairman of Proto Inc., to its 2025 TIME100 Health list in the 'Innovators' category, recognizing his work in hologram and AI technology designed to expand healthcare access. Proto's hologram technology enables doctors to appear virtually in remote clinics, includes AI translation tools, maintains HIPAA compliance, and has been cost-reduced to improve accessibility. The technology was first deployed at West Cancer Center in Tennessee in 2024, and multiple major clinics have since launched pilot programs to address caregiver shortages in underserved populations.WsjThe Hologram Doctor Will See You NowWest Cancer Center & Research Institute offered cancer patients in Tennessee and Mississippi hologram doctors instead of distant videoconferencing. The health system, with about 61 doctors and 19,240 new patients annually, uses concert-style projection technology. The main clinic is in Germantown, Tenn.